BioCeuticals Clinical TherActive Pain 60t

Description

High Strength Pain Relief with Standardised Salix and Boswellia
TherActive Pain is a broad spectrum formula for pain. It contains the highly bioavailable Theracurmin form of curcumin, together with willow bark, boswellia, Jamaican dogwood and ginger, to provide anti-inflammatory and analgesic support for acute and chronic pain conditions.

• Provides daily dose of clinically trialled amounts of the actives boswellic acid (120mg) and salicin (240mg) from Boswellia serrata and Salix alba, respectively.
• Contains highly bioavailable Theracurmin form of curcumin extract.
• Traditionally used in western herbal medicine for analgesic support for acute and chronic pain.
• Traditionally used for painful conditions whcih may include mild joint pain, rheumatism, mild headaches, neuralgia, cold symptoms, fever, dysmenorrhoea and dyspepsia.
• May support joint function in mild osteoarthritis.
• May help down-regulate inflammatory mediators.
• May relieve fever associated with the common cold and influenza.
• Provides antioxidant support.
• Standardised herbal extracts.

 

Each tablet contains:
Curcumin	10mg
from Theracurmin	100mg
Herbal extracts standardised equiv. to dry:
Salix alba (white willow) dry stem bark	10g
equiv. to salicin	80mg
Boswellia serrata (boswellia) sap resin	3.69g
equiv. to boswellic acid	120mg
Herbal extracts equiv. to dry:
Piscidia piscipula (Jamaican dogwood) stem bark	1g
Zingiber officinale (ginger) rhizome dry	670mg

 

No added dairy, gluten, shellfish, soy protein, yeast.
Vegan & vegetarian friendly.

If symptoms persist consult your healthcare practitioner.
Always read the label. Use only as directed.

Prescribing Information:
This product is not recommended for use in pregnancy or lactation.
The safety of oral doses of Theracurmin has been demonstrated in humans at levels up to 4000mg.
Curcumin lacks any major side effects.
Turmeric can cause gallbladder contractions and should not be used by individuals with gallstones or bile duct obstruction.
Turmeric has an antiplatelet effect and may cause excessive bleeding if used perioperatively. Advise patients to discontinue use at least two weeks before elective surgery.
Turmeric has an antiplatelet effect; avoid concomitant use with anticoagulant/antiplatelet drugs.
Animal studies suggest curcumin may reduce the efficacy of cyclophosphamide.
Concomitant use of salix and anticoagulant medications theoretically might increase the risk of bleeding due to decreased platelet aggregation.
In vitro studies show that Indian frankincense has immunostimulant properties. Theoretically, boswellia might decrease the effectiveness of immunosuppressive drugs.
In vitro evidence shows that Indian frankincense inhibits cytochrome P450 enzymes.
Jamaican dogwood may potentiate sedative effects of CNS depressant drugs.
Theoretically, excessive amounts of ginger might increase the risk of bleeding when used with anticoagulant/antiplatelet drugs.